Ludovic Helfgott/LinkedIn
Mar 11, 2026, 14:54
Ludovic Helfgott: Grateful for Generosity in Supporting Patients with Hemophilia and Hemoglobinopathies
Ludovic Helfgott, Executive Vice President, Product and Portfolio Strategy at Novo Nordisk, shared a post on LinkedIn:
“One of the most gratifying things in the life of a Chairman of a not-for-profit organization is to take money directly from the pockets of your great colleagues and friends …for a good cause …and still see them smile afterwards.
Thanks to Maziar Mike Doustdar, Martin Holst Lange, Kasper Bødker Mejlvang, Habib Bennaceur (and many others) for your wonderful generosity in helping patients with hemophilia, hemoglobinopathies or diabetes around the world.”
Stay updated with Hemostasis Today.
-
Jun 10, 2026, 15:23Jonathan Douxfils: New Data on Hemostasis, VTE, and Breast Cancer to Rethink the Reference Standard
-
Jun 10, 2026, 15:16Rena Hirani: The Role of Paper Substrates and Storage Conditions
-
Jun 10, 2026, 15:06Ashkan Golshani: Congratulations to Our Team on Recent Publications in Molecular Biology and AI-Driven Research
-
Jun 10, 2026, 14:52David Ferreira: Standardizing Thrombin Generation Testing in Portugal and Spain
-
Jun 10, 2026, 14:39Azlyat Mahmoud: Neuro-Hematology – Where Blood Disorders Meet Neurological Science
-
Jun 10, 2026, 13:22Lee Peter Bee: Silent mtDNA Mutations and the Secret Life of Ageing Clon
-
Jun 10, 2026, 13:19Abdul Mannan: A New DVT on Warfarin Is Not an INR Problem First
-
Jun 10, 2026, 13:06Ammar Alsughayir: Universal Access to Safe Blood – The 2026-2030 Action Framework
-
Jun 10, 2026, 13:01Tetsumei Urano: Promoting Movement and Health at APSTH 2026